Qube Research & Technologies (QRT)
PDSB icon

Qube Research & Technologies (QRT)’s PDS Biotechnology PDSB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,673
Closed -$59.9K – 3744
2024
Q3 		$59.9K Buy
15,673
+6,726
+75% +$22.4K ﹤0.01% 2831
2024
Q2 		$26.2K Buy
+8,947
New +$28.6K ﹤0.01% 2846
2023
Q2 		– Sell
-201,083
Closed -$1.24M – 2846
2023
Q1 		$1.24M Buy
+201,083
New +$1.65M 0.01% 1200
2022
Q2 		– Sell
-13,862
Closed -$86K – 2975
2022
Q1 		$86K Sell
13,862
-20,681
-60% -$128K ﹤0.01% 2101
2021
Q4 		$280K Buy
+34,543
New +$372K ﹤0.01% 1833

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PDSB Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of PDS Biotechnology (PDSB) in Q4 2024, closing a stake of 15,673 shares — an estimated $59.9K sold.

Qube Research & Technologies (QRT) first reported a position in PDSB in Q4 2021 and held it in 5 quarters. The position peaked at $1.24M in Q1 2023. 52 funds tracked by Wall St. Rank hold PDSB as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining PDS Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 15,673 PDS Biotechnology shares in Q4 2024, an estimated $59.9K.
  • Qube Research & Technologies (QRT) first reported a position in PDS Biotechnology in Q4 2021 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s PDS Biotechnology position peaked at $1.24M in Q1 2023.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.